glycemic control

Why dialing back diabetes treatment is a good ideaA new study has unbelievable findings about treating Medicare patients with diabetes.
FDA okays unique injectable for type 2 diabeticsFDA approved a new once-weekly, single-dose autoinjector device to improve glycemic control in adults with type 2 diabetes.
New diabetes drug set to rival TrulicityIf it is approved by FDA, an investigational drug to improve glycemic control in patients with type 2 diabetes will likely be a strong competitor to Eli Lilly’s dulaglutide (Trulicity).
CE: Diabetes: Setting the stride to improve glycemic control
CE: Diabetes: Setting the stride to improve glycemic control
Update on Diabetes TherapyDespite evidence that optimal glycemic control can help reduce disease progression and complications, most patients do not achieve recommended treatment goals.
Four areas of unnecessary senior healthcare
Four areas of unnecessary senior healthcareTwo reports highlight areas of elderly care that healthcare systems and health plans should avoid.
Aggressive blood sugar control slows diabetic eye disease progressionNIH-funded study shows less diabetic retinopathy progression among those who underwent intensive glycemic control.
Patient navigators can benefit diabetes outcomesStudy seeks to determine whether significant improvement in glycemic control can be achieved when regular coaching is part of the process.
First “follow-on” insulin glargine product approved to treat diabetesFDA approved insulin glargine injection (Basaglar, Eli Lilly) to improve glycemic control in patients with diabetes mellitus.
Tight glycemic control can do more harm to elderly patientsA new study reveals that tight glycemic control might not be the best goal for older adults with diabetes and other comorbidities.